Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01306539 · ClinicalTrials.gov registry record · NA
Neuropsychiatric Effects of Deep Brain Stimulation in Patients With Parkinson's Disease
A NA study of Parkinson's Disease, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT01306539: Completed NA study of Parkinson's Disease, sponsored by University of California, San Diego.
NCT01306539 is a NA study of Parkinson's Disease that has completed, run by University of California, San Diego. The registered enrollment target is 20 participants, below the 635-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01306539, a NA study of Parkinson's Disease, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Stimulation of the subthalamic nucleus will have effects on various aspects of neuropsychiatric function.
Primary Outcome
Participants will complete behavioral tasks at each of three visits to assess the effects of stimulation settings on task performance. At each research visit, behavior will be assessed beginning at 1 hour after the stimulation is adjusted to the experimental settings. Stimulation settings will be returned to each patient's treatment levels at the culmination of each visit.
Conditions Studied
Interventions
- PROCEDURE Stimulation of the subthalamic nucleus
Study Locations (1)
California
- Scripps Clinic Torrey Pines - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-07 |
| Est. Completion | 2014-12 |
| Phase | NA |
What the finished NCT01306539 record still lists
NCT01306539 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 635-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 1 intervention - of which Stimulation of the subthalamic nucleus is the first listed.
NCT01306539 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01306539 about?
NCT01306539 is a clinical study titled "Neuropsychiatric Effects of Deep Brain Stimulation in Patients With Parkinson's Disease". Stimulation of the subthalamic nucleus will have effects on various aspects of neuropsychiatric function.
What is the current status of trial NCT01306539?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2008-07. Estimated completion is 2014-12.
What conditions does trial NCT01306539 study?
This clinical trial studies the following conditions: Parkinson's Disease.
What interventions are being tested in trial NCT01306539?
The interventions under investigation include: Stimulation of the subthalamic nucleus (PROCEDURE).
Who is sponsoring clinical trial NCT01306539?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01306539 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01306539's enrollment target sits among peer trials
20 129th of 158 higher than 24 of 158 other Parkinson's Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinson's Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Novel DBS Stimulation Patterns for Treatment of Parkinson's Disease
RECRUITING · NA
-
Feasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease
RECRUITING · NA
-
Effects of Pallidal Deep Brain Stimulation Location on Motor Impairment in Parkinson's Disease
RECRUITING · NA
-
Remote Dynamic Cycling for the Customized Off-site Rehab in Parkinson's Disease
RECRUITING · NA
-
Deep Brain Stimulation Therapy in Movement Disorders
RECRUITING · NA
-
Combined STN and NBM Deep Brain Stimulation for Mild Cognitive Impairment in Parkinson's Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia